Shanghai Kai Kai Industry Co Ltd
SSE:600272
Shanghai Kai Kai Industry Co Ltd
Interest Income Expense
Shanghai Kai Kai Industry Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Kai Kai Industry Co Ltd
SSE:600272
|
Interest Income Expense
¥10.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-12%
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Interest Income Expense
¥71.6m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
52%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Interest Income Expense
¥134.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
23%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Interest Income Expense
¥429.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
30%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
37%
|
See Also
What is Shanghai Kai Kai Industry Co Ltd's Interest Income Expense?
Interest Income Expense
10.3m
CNY
Based on the financial report for Mar 31, 2024, Shanghai Kai Kai Industry Co Ltd's Interest Income Expense amounts to 10.3m CNY.
What is Shanghai Kai Kai Industry Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-12%
Over the last year, the Interest Income Expense growth was -54%.